- Home
- WINT vs SGN Comparison
WINT vs SGN Comparison
Compare WINT & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- SGN
- Stock Information
- Founded
- WINT 1992
- SGN 2019
- Country
- WINT United States
- SGN United States
- Employees
- WINT N/A
- SGN N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- SGN
- Sector
- WINT Health Care
- SGN
- Exchange
- WINT Nasdaq
- SGN Nasdaq
- Market Cap
- WINT 1.5M
- SGN 1.6M
- IPO Year
- WINT 1995
- SGN 2023
- Fundamental
- Price
- WINT $1.23
- SGN $0.71
- Analyst Decision
- WINT Hold
- SGN
- Analyst Count
- WINT 1
- SGN 0
- Target Price
- WINT $350.00
- SGN N/A
- AVG Volume (30 Days)
- WINT 7.7M
- SGN 58.2K
- Earning Date
- WINT 04-15-2025
- SGN 05-14-2025
- Dividend Yield
- WINT N/A
- SGN N/A
- EPS Growth
- WINT N/A
- SGN N/A
- EPS
- WINT N/A
- SGN N/A
- Revenue
- WINT N/A
- SGN $576,488.00
- Revenue This Year
- WINT N/A
- SGN N/A
- Revenue Next Year
- WINT N/A
- SGN N/A
- P/E Ratio
- WINT N/A
- SGN N/A
- Revenue Growth
- WINT N/A
- SGN 147.76
- 52 Week Low
- WINT $1.10
- SGN $0.65
- 52 Week High
- WINT $737.50
- SGN $36.72
- Technical
- Relative Strength Index (RSI)
- WINT 28.71
- SGN 33.31
- Support Level
- WINT $1.10
- SGN $0.66
- Resistance Level
- WINT $1.44
- SGN $0.85
- Average True Range (ATR)
- WINT 0.35
- SGN 0.08
- MACD
- WINT 0.18
- SGN 0.06
- Stochastic Oscillator
- WINT 5.46
- SGN 24.90
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.